Results 151 to 160 of about 21,895 (224)

Dupilumab for Treatment-refractory Bullous Pemphigoid: A Case Series of Six Patients. [PDF]

Acta Derm Venereol
Skovsgård CH, Kheirmand K, Touborg T, Vestergaard C, Bech R.   +4 more
europepmc   +1 more source

Secondary Syphilis With Concomitant Bullous Pemphigoid: A Case Report. [PDF]

Case Rep Dermatol Med
Rijal S, Sitaula D, Gyawalee M, Paudel V, Kafle M, Khadka A, Magar ST, Paudel B, Jha A, Amatya A, Kayastha B.   +10 more
europepmc   +1 more source

A Rare Case of Anti-Integrin β4 IgG-Positive Bullous Pemphigoid Lacking Mucosal Lesions. [PDF]

J Dermatol
Liu J, Sun C, Chen D, Guo X, Li J, Yang Z, Li X, Qian H.   +7 more
europepmc   +1 more source

Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab. [PDF]

Clin Cosmet Investig Dermatol
Yu L, Hu G, Zhang Q, Zhu Y, Chen L, Chen J.   +5 more
europepmc   +1 more source

Mucous membrane pemphigoid associated with thymoma: A rare cancer-associated immune manifestation. [PDF]

JAAD Case Rep
Fakih A, Makarem J, Sabbah N, Harb SB.
europepmc   +1 more source

Bullous Pemphigoid: A Focused Review on Antigen Epitopes. [PDF]

Exp Dermatol
Li J, Feng X, Zou M, Wei M, Li W.
europepmc   +1 more source

Increased risk of atrial fibrillation among patients with bullous pemphigoid: a nationwide cohort study in Taiwan. [PDF]

An Bras Dermatol
Chen TL, Huang WT, Wu CY, Loh CH, Huang HK, Ching-Chi C.   +5 more
europepmc   +1 more source

Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors. [PDF]

Acta Derm Venereol
Ikeda A, Tani N, Ishii N, Koga H, Yoshida Y.   +4 more
europepmc   +1 more source

An atypical presentation of Pembrolizumab-induced bullous pemphigoid in a patient with uterine serous carcinoma. [PDF]

Gynecol Oncol Rep
Chen RY, Vasavda C, Imadojemu S, Liu SW, Campos SM.   +4 more
europepmc   +1 more source

Esophagitis Dissecans Superficialis: An Uncommon Endoscopic Finding. [PDF]

Cureus
Perez Roa GF, Escandon-Espinoza YM, Lopez Garcia KD.   +2 more
europepmc   +1 more source